Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.11B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$568M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$468M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$464M |
| 5 |
Microsoft
MSFT
|
+$322M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$749M |
| 2 |
BPL
Buckeye Partners, L.P.
BPL
|
+$447M |
| 3 |
Alibaba
BABA
|
+$310M |
| 4 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$283M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$249M |
Sector Composition
| 1 | Technology | 12.94% |
| 2 | Financials | 10.53% |
| 3 | Healthcare | 9.91% |
| 4 | Consumer Discretionary | 8.59% |
| 5 | Communication Services | 6.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
ArcBest
ARCB
$1.6B
| $1.07M | ﹤0.01% |
38,906
+18,975
| +95% | +$524K |
|
2102
Bloomin' Brands
BLMN
$567M
| $1.07M | ﹤0.01% |
48,636
-241,821
| -83% | -$5.34M |
|
2103
Amicus Therapeutics
FOLD
$2.57B
| $1.07M | ﹤0.01% |
109,976
-68,491
| -38% | -$667K |
|
2104
DraftKings
DKNG
$21.2B
| $1.07M | ﹤0.01% |
+100,000
| New | +$1.07M |
|
2105
US Physical Therapy
USPH
$1.2B
| $1.07M | ﹤0.01% |
9,363
-5,383
| -37% | -$615K |
|
2106
Xtrackers Municipal Infrastructure Revenue Bond ETF
RVNU
$134M
| $1.07M | ﹤0.01% |
38,000
| – | – |
|
|
CCH.U
2107
DELISTED
Collier Creek Holdings Units, each consisting of one Class A ordinary share, $0.0001 par value, and
CCH.U
| $1.07M | ﹤0.01% |
100,000
| – | – |
|
|
CSR
2108
Centerspace
CSR
$972M
| $1.06M | ﹤0.01% |
14,672
+8,462
| +136% | +$614K |
|
2109
Lincoln Electric
LECO
$13.1B
| $1.06M | ﹤0.01% |
10,983
-466
| -4% | -$45.1K |
|
2110
Minerals Technologies
MTX
$2.03B
| $1.06M | ﹤0.01% |
18,437
+9,926
| +117% | +$572K |
|
2111
iRhythm Technologies
IRTC
$5.55B
| $1.06M | ﹤0.01% |
15,546
+4,064
| +35% | +$277K |
|
|
MYOK
2112
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.06M | ﹤0.01% |
14,529
+4,575
| +46% | +$333K |
|
2113
Invesco Dorsey Wright Consumer Staples Momentum ETF
PSL
$96.5M
| $1.06M | ﹤0.01% |
14,278
+16
| +0.1% | +$1.19K |
|
2114
Hilltop Holdings
HTH
$2.18B
| $1.06M | ﹤0.01% |
42,392
+31,477
| +288% | +$785K |
|
2115
Smith & Wesson
SWBI
$411M
| $1.06M | ﹤0.01% |
148,093
-46,777
| -24% | -$334K |
|
|
GOOS
2116
Canada Goose Holdings
GOOS
$1.35B
| $1.06M | ﹤0.01% |
29,104
-346
| -1% | -$12.5K |
|
|
WDR
2117
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $1.06M | ﹤0.01% |
63,076
-20,598
| -25% | -$345K |
|
|
INVX
2118
Innovex International, Inc.
INVX
$1.17B
| $1.05M | ﹤0.01% |
22,422
+2,020
| +10% | +$94.8K |
|
2119
SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.88B
| $1.05M | ﹤0.01% |
38,876
+1,664
| +4% | +$44.8K |
|
|
CVA
2120
DELISTED
Covanta Holding Corporation
CVA
| $1.05M | ﹤0.01% |
70,563
+50,529
| +252% | +$750K |
|
2121
Galapagos
GLPG
$2.18B
| $1.05M | ﹤0.01% |
5,056
+892
| +21% | +$185K |
|
2122
PJT Partners
PJT
$4.54B
| $1.05M | ﹤0.01% |
23,172
+15,264
| +193% | +$688K |
|
2123
Conduent
CNDT
$458M
| $1.04M | ﹤0.01% |
167,670
+118,421
| +240% | +$735K |
|
2124
Equinor
EQNR
$62B
| $1.04M | ﹤0.01% |
52,095
+27,225
| +109% | +$542K |
|
2125
Heron Therapeutics
HRTX
$235M
| $1.04M | ﹤0.01% |
44,073
-102,745
| -70% | -$2.42M |
|